Goal is to analyse the clinical safety and efficacy of the CARESTO® heal Stent within standard clinical routine for the treatment of patients with symptomatic non-stenotic carotid disease (SyNC) and with high-risk plaque features for stroke recurrence compared to medical treatment alone with respect to the mid- and long-term clinical outcomes.
Patients diagnosed with acute ischemic stroke or acute retinal artery ischemia within the last two weeks related to symptomatic non-stenotic carotid disease (SyNC) and high-risk carotid plaque features
Ipsilateral acute ischemic stroke must be determined by acute ischemic infarct on DWI or CT OR
by neurological symptoms indicating ipsilateral cortical deficits consistent with ischemia in the territory of the internal carotid artery and after exclusion of a significant microangiopathy
Acute retinal artery ischemia must be determined by ophthalmologic examination
Patients with acute complete occlusion of the carotid artery in an emergency setting
Incidence of acute infarcts in other vascular (i.e., not ipsilateral carotid) territories
Small vessel disease
Large vessel atherosclerotic disease ≥ 50%